Diagnosis and Treatment > Investigation > Progesterone

You are looking at 1 - 6 of 6 items

Himangshu S Bose Laboratory of Biochemistry, Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA
Memorial University Medical Center, Savannah, Georgia, USA

Search for other papers by Himangshu S Bose in
Google Scholar
PubMed
Close
,
Alan M Rice Laboratory of Biochemistry, Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA
Pediatric Endocrinology and Diabetes Center, Kalispell Regional Medical Center, Kalispell, Montana, USA

Search for other papers by Alan M Rice in
Google Scholar
PubMed
Close
,
Brendan Marshall Anatomy and Pathology, Augusta State University, Augusta, Georgia, USA

Search for other papers by Brendan Marshall in
Google Scholar
PubMed
Close
,
Fadi Gebrail Laboratory of Biochemistry, Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA
Laboratory of Pathology, Memorial University Medical Center, Savannah, Georgia, USA

Search for other papers by Fadi Gebrail in
Google Scholar
PubMed
Close
,
David Kupshik Laboratory of Biochemistry, Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA

Search for other papers by David Kupshik in
Google Scholar
PubMed
Close
, and
Elizabeth W Perry Anatomy and Pathology, Augusta State University, Augusta, Georgia, USA

Search for other papers by Elizabeth W Perry in
Google Scholar
PubMed
Close

Summary

Steroid hormones are essential for the survival of all mammals. In adrenal glands and gonads, cytochrome P450 side chain cleavage enzyme (SCC or CYP11A1), catalyzes conversion of cholesterol to pregnenolone. We studied a patient with ambiguous genitalia by the absence of Müllerian ducts and the presence of an incompletely formed vagina, who had extremely high adrenocorticotropic hormone (ACTH) and reduced pregnenolone levels with enlarged adrenal glands. The testes revealed seminiferous tubules, stroma, rete testis with interstitial fibrosis and reduced number of germ cells. Electron microscopy showed that the patient’s testicular mitochondrial size was small with little SCC expression within the mitochondria. The mitochondria were not close to the mitochondria-associated ER membrane (MAM), and cells were filled with the microfilaments. Our result revealed that absence of pregnenolone is associated with organelle stress, leading to altered protein organization that likely created steric hindrance in testicular cells.

Learning points:

  • Testes revealed seminiferous tubules, stroma, rete testis with interstitial fibrosis and reduced number of germ cells;

  • Testicular mitochondrial size was small with little SCC expression within the mitochondria;

  • Absence of pregnenolone is associated with organelle stress.

Open access
Jasmeet Kaur Laboratory of Biochemistry, Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA
Anderson Cancer Institute, Memorial University Medical Center, Savannah, Georgia, USA

Search for other papers by Jasmeet Kaur in
Google Scholar
PubMed
Close
,
Alan M Rice Division of Pediatric Endocrinology, Memorial University Medical Center, Savannah, Georgia, USA
Augusta University School of Medicine, Augusta, Georgia, USA
Neonatology Intensive Care Unit, Memorial University Medical Center, Georgia, USA

Search for other papers by Alan M Rice in
Google Scholar
PubMed
Close
,
Elizabeth O’Connor Laboratory of Biochemistry, Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA

Search for other papers by Elizabeth O’Connor in
Google Scholar
PubMed
Close
,
Anil Piya Division of Pediatric Endocrinology, Memorial University Medical Center, Savannah, Georgia, USA
Neonatology Intensive Care Unit, Memorial University Medical Center, Georgia, USA

Search for other papers by Anil Piya in
Google Scholar
PubMed
Close
,
Bradley Buckler Neonatology Intensive Care Unit, Memorial University Medical Center, Georgia, USA

Search for other papers by Bradley Buckler in
Google Scholar
PubMed
Close
, and
Himangshu S Bose Laboratory of Biochemistry, Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA
Anderson Cancer Institute, Memorial University Medical Center, Savannah, Georgia, USA

Search for other papers by Himangshu S Bose in
Google Scholar
PubMed
Close

Congenital adrenal hyperplasia (CAH) is caused by mutations in cytochrome P450 side chain cleavage enzyme (CYP11A1 and old name, SCC). Errors in cholesterol side chain cleavage by the mitochondrial resident CYP11A1 results in an inadequate amount of pregnenolone production. This study was performed to evaluate the cause of salt-losing crisis and possible adrenal failure in a pediatric patient whose mother had a history of two previous stillbirths and loss of another baby within a week of birth. CAH can appear in any population in any region of the world. The study was conducted at Memorial University Medical Center and Mercer University School of Medicine. The patient was admitted to Pediatric Endocrinology Clinic due to salt-losing crisis and possible adrenal failure. The patient had CAH, an autosomal recessive disease, due to a novel mutation in exon 5 of the CYP11A1 gene, which generated a truncated protein of 286 amino acids compared with wild-type protein that has 521 amino acids (W286X). Although unrelated, both parents are carriers. Mitochondrial protein import analysis of the mutant CYP11A1 in steroidogenic MA-10 cells showed that the protein is imported in a similar fashion as observed for the wild-type protein and was cleaved to a shorter fragment. However, mutant’s activity was 10% of that obtained for the wild-type protein in non-steroidogenic COS-1 cells. In a patient of Mexican descent, a homozygous CYP11A1 mutation caused CAH, suggesting that this disease is not geographically restricted even in a homogeneous population.

Learning points:

  • Novel mutation in CYP11A1 causes CAH;

  • This is a pure population from Central Mexico;

  • Novel mutation created early truncated protein.

Open access
Jasmeet Kaur Division of Biomedical Science, Department of Biochemistry, Mercer University School of Medicine and Memorial University Medical Center, Hoskins Research Building, 4700 Waters Avenue, Savannah, Georgia, 31404, USA

Search for other papers by Jasmeet Kaur in
Google Scholar
PubMed
Close
,
Luis Casas Division of Endocrinology, Department of Pediatrics, University of North Dakota, Fargo, North Dakota, USA

Search for other papers by Luis Casas in
Google Scholar
PubMed
Close
, and
Himangshu S Bose Division of Biomedical Science, Department of Biochemistry, Mercer University School of Medicine and Memorial University Medical Center, Hoskins Research Building, 4700 Waters Avenue, Savannah, Georgia, 31404, USA
Anderson Cancer Institute, Memorial University Medical Center, Savannah, Georgia, 31404, USA

Search for other papers by Himangshu S Bose in
Google Scholar
PubMed
Close

Summary

Lipoid congenital adrenal hyperplasia (lipoid CAH), the most severe form of CAH, is most commonly caused by mutations in steroidogenic acute regulatory protein (STAR), which is required for the movement of cholesterol from the outer to the inner mitochondrial membranes to synthesize pregnenolone. This study was performed to evaluate whether the salt-losing crisis and the adrenal inactivity experienced by a Scandinavian infant is due to a de novo STAR mutation. The study was conducted at the University of North Dakota, the Mercer University School of Medicine and the Memorial University Medical Center to identify the cause of this disease. The patient was admitted to a pediatric endocrinologist at the Sanford Health Center for salt-losing crisis and possible adrenal failure. Lipoid CAH is an autosomal recessive disease, we identified two de novo heterozygous mutations (STAR c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R193X)) in the STAR gene, causing lipoid CAH. New onset lipoid CAH can occur through de novo mutations and is not restricted to any specific region of the world. This Scandinavian family was of Norwegian descent and had lipoid CAH due to a mutation in S TAR exons 4 and 5. Overexpression of the STAR p.N148K mutant in nonsteroidogenic COS-1 cells supplemented with an electron transport system showed activity similar to the background level, which was ∼10% of that observed with wild-type (WT) STAR. Protein-folding analysis showed that the finger printing of the STAR p.N148K mutant is also different from the WT protein. Inherited STAR mutations may be more prevalent in some geographical areas but not necessarily restricted to those regions.

Learning points

  • STAR mutations cause lipoid CAH.

  • This is a pure population from a caucasian family.

  • Mutation ablated STAR activity.

  • The mutation resulted in loosely folded conformation of STAR.

Open access
Nicole Maison Endocrine Research Unit, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Nicole Maison in
Google Scholar
PubMed
Close
,
Esther Korpershoek Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands

Search for other papers by Esther Korpershoek in
Google Scholar
PubMed
Close
,
Graeme Eisenhofer Department of Medicine III, Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany

Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Close
,
Mercedes Robledo Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO) and ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain

Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Close
,
Ronald de Krijger Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
Department of Pathology, Reinier de Graaf Hospital, Delft, The Netherlands

Search for other papers by Ronald de Krijger in
Google Scholar
PubMed
Close
, and
Felix Beuschlein Endocrine Research Unit, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Close

Summary

Pheochromocytomas (PCC) and paraganglioma (PGL) are rare neuroendocrine tumors arising from chromaffin cells of the neural crest. Mutations in the RET-proto-oncogene are associated with sporadic pheochromocytoma, familial or sporadic medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2. In the past, only few cases of pigmented PCCs, PGLs, and one case of pigmented MTC have been reported in the literature. Herein, we present the case of a 77-year old woman with a history of Tako-tsubo-cardiomyopathy and laboratory, as well as radiological, high suspicion of pheochromocytoma, who underwent left-sided adrenalectomy. The 3 cm tumor, which was located on the upper pole of the left adrenal, appeared highly pigmented with dark red to black color. Histologic examinations revealed highly pleomorphic cells with bizarre, huge hyperchromatic nuclei, that immunohistochemically were positive for chromogranin A and synaptophysin, focally positive for HMB45 and negative for melan A. These clinical and pathological features led to the diagnosis of the rare variant of a melanotic ‘black’ pheochromocytoma. In our case a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy) was detected by targeted next generation sequencing. In summary, this case represents a rare variant of catecholamine-producing tumor with distinct histological features. A potential relationship between the phenotype, the cellular origin and the genetic alterations is discussed.

Learning points

  • Pheochromocytoma is a rare neuroendocrine tumor.

  • Pigmentation is seen in several types of tumors arising from the neural crest. The macroscopic black aspect can mislead to the diagnosis of a metastasis deriving from a malignant melanoma.

  • RET mutation are seen in catecholamine and non-catecholamine producing tumors of the same cellular origin.

Open access
W C Candy Sze Department of Endocrinology, St Bartholomew's Hospital, London, EC1A 7BE, UK

Search for other papers by W C Candy Sze in
Google Scholar
PubMed
Close
,
Joe McQuillan Department of Ophthalmology, St Bartholomew's Hospital, London, EC1A 7BE, UK

Search for other papers by Joe McQuillan in
Google Scholar
PubMed
Close
,
P Nicholas Plowman Department of Clinical Oncology, St Bartholomew's Hospital, London, EC1A 7BE, UK

Search for other papers by P Nicholas Plowman in
Google Scholar
PubMed
Close
,
Niall MacDougall Department of Clinical Oncology, St Bartholomew's Hospital, London, EC1A 7BE, UK

Search for other papers by Niall MacDougall in
Google Scholar
PubMed
Close
,
Philip Blackburn Gamma Knife Unit, St Bartholomew's Hospital, London, EC1A 7BE, UK

Search for other papers by Philip Blackburn in
Google Scholar
PubMed
Close
,
H Ian Sabin Gamma Knife Unit, St Bartholomew's Hospital, London, EC1A 7BE, UK

Search for other papers by H Ian Sabin in
Google Scholar
PubMed
Close
,
Nadeem Ali Department of Ophthalmology, St Bartholomew's Hospital, London, EC1A 7BE, UK

Search for other papers by Nadeem Ali in
Google Scholar
PubMed
Close
, and
William M Drake Department of Endocrinology, St Bartholomew's Hospital, London, EC1A 7BE, UK

Search for other papers by William M Drake in
Google Scholar
PubMed
Close

Summary

We report three patients who developed symptoms and signs of ocular neuromyotonia (ONM) 3–6 months after receiving gamma knife radiosurgery (GKS) for functioning pituitary tumours. All three patients were complex, requiring multi-modality therapy and all had received prior external irradiation to the sellar region. Although direct causality cannot be attributed, the timing of the development of the symptoms would suggest that the GKS played a contributory role in the development of this rare problem, which we suggest clinicians should be aware of as a potential complication.

Learning points

  • GKS can cause ONM, presenting as intermittent diplopia.

  • ONM can occur quite rapidly after treatment with GKS.

  • Treatment with carbamazepine is effective and improve patient's quality of life.

Open access
Sunita M C De Sousa Department of Endocrinology, St Vincent's Hospital, Sydney, New South Wales, Australia
Hormones and Cancer Group, Garvan Institute of Medical Research, 384 Victoria Street, Sydney, New South Wales, 2010, Australia

Search for other papers by Sunita M C De Sousa in
Google Scholar
PubMed
Close
,
Peter Earls Department of Anatomical Pathology, St Vincent's Hospital, Sydney, New South Wales, Australia

Search for other papers by Peter Earls in
Google Scholar
PubMed
Close
, and
Ann I McCormack Department of Endocrinology, St Vincent's Hospital, Sydney, New South Wales, Australia
Hormones and Cancer Group, Garvan Institute of Medical Research, 384 Victoria Street, Sydney, New South Wales, 2010, Australia

Search for other papers by Ann I McCormack in
Google Scholar
PubMed
Close

Summary

Pituitary hyperplasia (PH) occurs in heterogeneous settings and remains under-recognised. Increased awareness of this condition and its natural history should circumvent unnecessary trans-sphenoidal surgery. We performed an observational case series of patients referred to a single endocrinologist over a 3-year period. Four young women were identified with PH manifesting as diffuse, symmetrical pituitary enlargement near or touching the optic apparatus on MRI. The first woman presented with primary hypothyroidism and likely had thyrotroph hyperplasia given prompt resolution with thyroxine. The second and third women were diagnosed with pathological gonadotroph hyperplasia due to primary gonadal insufficiency, with histopathological confirmation including gonadal-deficiency cells in the third case where surgery could have been avoided. The fourth woman likely had idiopathic PH, though she had concomitant polycystic ovary syndrome which is a debated cause of PH. Patients suspected of PH should undergo comprehensive hormonal, radiological and sometimes ophthalmological evaluation. This is best conducted by a specialised multidisciplinary team with preference for treatment of underlying conditions and close monitoring over surgical intervention.

Learning points

  • Normal pituitary dimensions are influenced by age and gender with the greatest pituitary heights seen in young adults and perimenopausal women.

  • Pituitary enlargement may be seen in the settings of pregnancy, end-organ insufficiency with loss of negative feedback, and excess trophic hormone from the hypothalamus or neuroendocrine tumours.

  • PH may be caused or exacerbated by medications including oestrogen, GNRH analogues and antipsychotics.

  • Management involves identification of cases of idiopathic PH suitable for simple surveillance and reversal of pathological or iatrogenic causes where they exist.

  • Surgery should be avoided in PH as it rarely progresses.

Open access